The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers-Reference-Cited by-同舟云学术

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Published:2011-07 Issue:4 Volume:7 Page:386
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Mattsson Niklas¹,Andreasson Ulf¹,Persson Staffan¹,Arai Hiroyuki²,Batish Sat Dev³,Bernardini Sergio⁴,Bocchio‐Chiavetto Luisella⁵,Blankenstein Marinus A.⁶,Carrillo Maria C.⁷,Chalbot Sonia⁸,Coart Els⁹,Chiasserini Davide¹⁰,Cutler Neal¹¹,Dahlfors Gunilla¹²,Duller Stefan¹³,Fagan Anne M.¹⁴,Forlenza Orestes¹⁵,Frisoni Giovanni B.⁵,Galasko Douglas¹⁶,Galimberti Daniela¹⁷,Hampel Harald¹⁸,Handberg Aase¹⁹,Heneka Michael T.²⁰,Herskovits Adrianna Z.²¹,Herukka Sanna‐Kaisa²²,Holtzman David M.¹⁴,Humpel Christian²³,Hyman Bradley T.²¹,Iqbal Khalid⁸,Jucker Mathias²⁴,Kaeser Stephan A.²⁴,Kaiser Elmar²⁵,Kapaki Elisabeth²⁶,Kidd Daniel²⁷,Klivenyi Peter²⁸,Knudsen Cindy S.¹⁹,Kummer Markus P.²⁰,Lui James²⁹,LladÓ Albert³⁰,Lewczuk Piotr³¹,Li Qiao‐Xin³²,Martins Ralph²⁹,Masters Colin³²,McAuliffe John³,Mercken Marc³³,Moghekar Abhay³⁴,Molinuevo JosÉ Luis³⁰,Montine Thomas J.³⁵,Nowatzke William¹¹,O'Brien Richard³⁴,Otto Markus³⁶,Paraskevas George P.²⁶,Parnetti Lucilla¹⁰,Petersen Ronald C.³⁷,Prvulovic David¹⁸,Reus Herman P.M.³⁸³⁹,Rissman Robert A.¹⁶,Scarpini Elio¹⁷,Stefani Alessandro⁴⁰,Soininen Hilkka²²,Schröder Johannes²⁵,Shaw Leslie M.⁴¹,Skinningsrud Anders⁴²,Skrogstad Brith⁴²,Spreer Annette⁴³,Talib Leda¹⁵,Teunissen Charlotte⁶,Trojanowski John Q.⁴¹,Tumani Hayrettin³⁶,Umek Robert M.⁴⁴,Van Broeck Bianca³³,Vanderstichele Hugo⁹,Vecsei Laszlo²⁸,Verbeek Marcel M.³⁸³⁹,Windisch Manfred¹³,Zhang Jing³⁵,Zetterberg Henrik¹,Blennow Kaj¹

Affiliation:

1. Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry the Sahlgrenska Academy at the University of GothenburgSahlgrenska University HospitalMölndalSweden

2. Department of Geriatrics and Gerontology, Institute of Development, Aging and CancerTohoku UniversitySendaiJapan

3. Athena Diagnostics Inc.WorchesterMAUSA

4. Department Biochimica Clinica, PoliclinicoUniversity of Tor VergataRomeItaly

5. IRCCS Centro S. Giovanni di Dio—FatebenefratelliBresciaItaly

6. Department of Clinical ChemistryVU University Medical CenterAmsterdamThe Netherlands

7. The Alzheimer's AssociationChicagoILUSA

8. Department of NeurochemistryNew York State Institute for Basic Research in Developmental DisabilitiesStaten IslandNYUSA

9. InnogeneticsGhentBelgium

10. Section of Neurology, Laboratory of Clinical Neurochemistry, Centre for Memory DisturbancesUniversity of PerugiaPerugiaItaly

11. Worldwide Clinical TrialsKing of PrussiaPAUSA

12. Department of Clinical Chemistry, Karolinska University LaboratoryKarolinska University HospitalStockholmSweden

13. JSW Life Sciences GmbHGrambachAustria

14. Department of Neurology, Alzheimer's Disease Research Center, Hope Center for Neurological DisordersWashington University School of MedicineSt. LouisMOUSA

15. Laboratory of Neuroscience (LIM 27), Department and Institute of Psychiatry, Faculty of MedicineUniversity of Sao PauloSao PauloBrazil

16. Department of NeurosciencesUCSD School of MedicineLa JollaCAUSA

17. Department of Neurological SciencesUniversity of MilanMilanItaly

18. Department of Psychiatry, Psychosomatic Medicine and PsychotherapyGoethe UniversityFrankfurtGermany

19. Department of Clinical Biochemistry, Aarhus HospitalAarhus University HospitalAarhusDenmark

20. Klinische Neurowissenschaften, Klinik und Poliklinik für NeurologieUniversity of BonnBonnGermany

21. MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Massachusetts Alzheimer Disease Research CenterHarvard Medical SchoolCharlestownMAUSA

22. Department of NeurologyUniversity of Eastern Finland, Kuopio University HospitalKuopioFinland

23. Laboratory of Psychiatry and Experimental Alzheimers ResearchInnsbruck Medical UniversityInnsbruckAustria

24. Department of Cellular Neurology, Hertie‐Institute for Clinical Brain ResearchUniversity of Tübingen and DZNE—German Center for Neurodegenerative DiseasesTübingenGermany

25. Section of Geriatric PsychiatryUniversity of HeidelbergHeidelbergGermany

26. 1st Department of NeurologyEginition Hospital, National and Kapodistrian University of AthensAthensGreece

27. Janssen Alzheimer Immunotherapy Research and DevelopmentSouth San FranciscoCAUSA

28. Department of NeurologyUniversity of SzegedSzegedHungary

29. Centre of Excellence for Alzheimer's Disease Research and Care, School of Exercise, Biomedical and Health SciencesEdith Cowan UniversityPerthAustralia

30. Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology ServiceHospital Clínic, Institut d'InvestigaciÓ BiomÉdica August Pi i Sunyer (IDIBAPS)BarcelonaSpain

31. Department of Psychiatry and PsychotherapyUniversitätsklinikum ErlangenErlangenGermany

32. Neuropathology Research Group, The Mental Health Research InstituteUniversity of MelbourneMelbourneAustralia

33. Janssen Pharmaceutica, J&JBeerseBelgium

34. Department of NeurologyJohns Hopkins School of MedicineBaltimoreMDUSA

35. Department of PathologyUniversity of WashingtonSeattleWAUSA

36. Department of NeurologyUniversity of UlmUlmGermany

37. Alzheimer's Disease Research CenterMayo ClinicRochesterMNUSA

38. Department of Neurology, Radboud University Nijmegen Medical CentreDonders Institute for Brain, Cognition and Behaviour, Alzheimer Centre NijmegenNijmegenThe Netherlands

39. Department of Laboratory Medicine, Radboud University Nijmegen Medical CentreDonders Institute for Brain, Cognition and Behaviour, Alzheimer Centre NijmegenNijmegenThe Netherlands

40. IRCCS Fondazione S. LuciaRomeItaly

41. Department of Pathology and Laboratory MedicineUniversity of Pennsylvania Medical Center (ADNI Biomarker Core)PhiladelphiaPAUSA

42. Department of Clinical Biochemistry, Center of Laboratory MedicineAkershus University HospitalOsloNorway

43. Department of NeurologyUniversity of GöttingenGöttingenGermany

44. Meso Scale DiscoveryGaithersburgMDUSA

Funder

Alzheimer's Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2011.05.2243

Reference30 articles.

1. CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

2. Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

3. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42in humans

4. PET imaging of amyloid deposition in patients with mild cognitive impairment

5. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Cited by 350 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RESTING STATE ELECTROENCEPHALOGRAPHIC ALPHA RHYTHMS ARE SENSITIVE TO ALZHEIMER’S DISEASE MILD COGNITIVE IMPAIRMENT PROGRESSION AT A 6-MONTH FOLLOW-UP;Neurobiology of Aging;2024-02

2. Influence of Physiological Variables and Comorbidities on Plasma Aβ40, Aβ42, and p-tau181 Levels in Cognitively Unimpaired Individuals;International Journal of Molecular Sciences;2024-01-25

3. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies;Journal of Extracellular Vesicles;2023-12-29

4. Correlational analyses of biomarkers that are harmonized through a bridging study due to measurement errors;Statistical Methods in Medical Research;2023-11-22

5. Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia;Journal of Alzheimer's Disease;2023-11-21